Objetivo
NanoAthero aims to have demonstration of initial clinical feasibility of nanosystems for targeted imaging and treatment of advanced atherosclerotic disease in humans. The nanosystems are assemblies of following components: nanocarrier, targeting, imaging agent/drug. They have proven safety records, and strong preliminary in vitro and in vivo proofs of efficacy are available. Partners have patented and provided evidence of efficacy of carriers and ligands. Over 5 years, NanoAthero will integrate GMP production, the initiation of clinical investigations in high-risk patients, including the preparation of regulatory dossiers, risk and ethical assessments, and the evaluation of the performance of optimized diagnostic and therapeutic compounds. NanoAthero offers a unique opportunity for combining in-depth knowledge of nanocarrier bioengineering and production with state-of the art expertise in imaging and treatment of cardiovascular patients providing a full bench-to-bedside framework within one collaborative consortium of 16 partners from academia, a European association, SMEs and a large pharmaceutical company. NanoAthero gathers together leading chemists, engineers, pharmacists, biologists, toxicologists, clinicians, analysts, ethicists and key-opinion leaders in the field of cardiovascular medicine and early drug development.
In NanoAthero, the nanocarriers carrying compounds to visualize thrombus or vulnerable plaques, or to deliver therapeutic agents should be suitable for proof-of-concept in patients. Phase I clinical trials targeting pivotal pathways in atherothrombosis will be performed with nanosystems for diagnosis and treatment of carotid atheroma. NanoAthero aims to propose nanosystems for thrombus imaging, stroke treatment and plaque stabilization in high-risk patients. Molecular imaging and therapeutic treatments in NanoAthero are based on feasible approaches.
Ámbito científico
Convocatoria de propuestas
FP7-NMP-2012-LARGE-6
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
75654 Paris
Francia
Ver en el mapa
Participantes (15)
75012 Paris
Ver en el mapa
75015 PARIS
Ver en el mapa
1105AZ Amsterdam
Ver en el mapa
8010 Graz
Ver en el mapa
5230 Odense M
Ver en el mapa
91054 Erlangen
Ver en el mapa
7522 NB Enschede
Ver en el mapa
80539 Munchen
Ver en el mapa
75015 PARIS 15
Ver en el mapa
4016 BASEL
Ver en el mapa
67017 TEL AVIV-JAFFO
Ver en el mapa
10115 Berlin
Ver en el mapa
1085 Budapest
Ver en el mapa
20134 Milano
Ver en el mapa
IV51 9YD ISLE OF SKYE
Ver en el mapa